Our CLABSI patients had a high mortality, although antimicrobial therapy was appropriate. Gram-negative bacteria were responsible for almost half of the cases and there was a high rate of bacteria resistance to extended-spectrum antibiotics” Yokota et al (2016).
Abstract:
BACKGROUND: Central venous catheters are significant risk factors for bloodstream infection (BSI), which are directly associated with increased morbidity and mortality.
METHODS: This study was a retrospective cohort study for the time period of July 2011-June 2014 in patients with central line-associated bloodstream infection (CLABSI) to determine the microbiological profile and antimicrobial adequacy of patients with CLABSI in a tertiary hospital.
[ctt link=”a5JYK” template=”1″]ReTweet if useful… Adequacy of antimicrobial therapy in patients with CLABSI https://ctt.ec/a5JYK+ @ivteam #ivteam[/ctt]
RESULTS: One hundred and twenty-one CLABSI cases were identified. Ninety-two percent (n = 111) of patients had monomicrobial BSI. Gram-negative bacteria were the most prevalent (49%, n = 63), with Klebsiella spp. predominating (30%, n = 19). Among the Gram-positive bacteria (n = 43, 33%), coagulase-negative staphylococci was the major pathogen (58%, n = 25), and all isolates were methicillin resistant. Antimicrobial therapy was assessed as adequate in 81% (n = 98) of cases. In-hospital mortality was 36% (n = 43 cases).
CONCLUSION: Our CLABSI patients had a high mortality, although antimicrobial therapy was appropriate. Gram-negative bacteria were responsible for almost half of the cases and there was a high rate of bacteria resistance to extended-spectrum antibiotics.
[button link=”https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179579/pdf/fpubh-04-00284.pdf” color=”default”]Full Text[/button]
[spacer height=”20px”]
Reference:
Yokota, P.K., Marra, A.R., Belucci, T.R., Victor, E.D., Dos Santos, O.F. and Edmond, M.B. (2016) Outcomes and Predictive Factors Associated with Adequacy of Antimicrobial Therapy in Patients with Central Line-Associated Bloodstream Infection. Frontiers in Public Health. 4, p.284. eCollection 2016.
doi: 10.3389/fpubh.2016.00284.
Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]